Publications by authors named "Clemens Unger"

Claim this Profile
D
Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial.
Kristin Werner, Daniela Küllenberg de Gaudry, Lenka A Taylor, Tobias Keck, Clemens Unger

Lipids Health Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Marine Phospholipids Extract on the Lipid Levels of Metastatic and Nonmetastatic Prostate Cancer Patients.
Daniela Küllenberg de Gaudry, Lenka A Taylor, Jessica Kluth, Tobias Hübschle, Jonas Fritzsche, Clemens Unger

Int Sch Res Notices· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays.
Stephanie Howe, Dorina Zöphel, Harini Subbaraman, Clemens Unger, Jana Held

Antimicrob Agents Chemother· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization and comparison of 2 distinct epidemic community-associated methicillin-resistant Staphylococcus aureus clones of ST59 lineage.
Chih-Jung Chen, Clemens Unger, Wolfgang Hoffmann, Jodi A Lindsay, Yhu-Chering Huang

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nasal epithelial receptor for Staphylococcus aureus WTA governs adhesion to epithelial cells and modulates nasal colonization.
Stefanie Baur, Maren Rautenberg, Michaela Faulstich, Timo Grau, Yannik Severin, Clemens Unger

PLoS Pathog· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose.
Bernhard Krismer, Manuel Liebeke, Daniela Janek, Mulugeta Nega, Maren Rautenberg, Clemens Unger

PLoS Pathog· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-escalation study of regorafenib (BAY 73-4506), an inhibitor of oncogenic, angiogenic, and stromal kinases, in patients with advanced solid tumors.
Klaus Mross, Annette Frost, Simone Steinbild, Susanne Hedbom, Martin Büchert, Clemens Unger

Clin Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: an in vitro and in vivo evaluation study.
Bakheet Elsadek, Ralph Graeser, Norbert Esser, Cynthia Schäfer-Obodozie, Khalid Abu Ajaj, Clemens Unger

Eur J Cancer· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
c-kit (CD117) expression in human tumors and its prognostic value: an immunohistochemical analysis.
Michael Medinger, Manuela Kleinschmidt, Klaus Mross, Barbara Wehmeyer, Clemens Unger

Pathol Oncol Res· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of an albumin-binding prodrug of Doxorubicin that is cleaved by prostate-specific antigen.
Bakheet Elsadek, Ralph Graeser, André Warnecke, Clemens Unger, Tahia Saleem

ACS Med Chem Lett· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase IA, open-label, dose-escalating study of PTK787/ZK 222584 administered orally on a continuous dosing schedule in patients with advanced cancer.
Joachim Drevs, Michael Medinger, Klaus Mross, Stefan Fuxius, Juergen Hennig, Clemens Unger

Anticancer Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization.
Marc Burian, Maren Rautenberg, Thomas Kohler, Michaela Fritz, Bernhard Krismer, Clemens Unger

J Infect Dis· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-time-in-man and pharmacokinetic study of weekly oral perifosine in patients with solid tumours.
Clemens Unger, Wolfgang Berdel, Axel-R Hanauske, Herbert Sindermann, Jürgen Engel

Eur J Cancer· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marine phospholipids--a promising new dietary approach to tumor-associated weight loss.
Lenka A Taylor, Lars Pletschen, Jann Arends, Clemens Unger, Ulrich Massing

Support Care Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.
Peter Jantscheff, Vittorio Ziroli, Norbert Esser, Ralph Graeser, Jessica Kluth, Clemens Unger

Clin Exp Metastasis· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of the angiogenesis inhibitor BIBF 1120 in patients with advanced solid tumors.
Klaus Mross, Martin Stefanic, Daniela Gmehling, Annette Frost, Franziska Baas, Clemens Unger

Clin Cancer Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: results from a phase II randomized, factorial, double-blind study of Cediranib in patients with advanced solid tumors.
Marlies H G Langenberg, Carla M L van Herpen, Johann De Bono, Jan H M Schellens, Clemens Unger

J Clin Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour Biology: tumour-associated inflammation versus antitumor immunity.
Boris Müller-Hübenthal, Marc Azemar, Dirk Lorenzen, Michael Huber, Marina A Freudenberg, Clemens Unger

Anticancer Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II STUdy with 3rd- or 4th-line bendamustine (flat dose) therapy in patients with metastatic breast cancer.
Simone Steinbild, Annette Frost, Brigitte Häring, Clemens Unger, Klaus Mross

Onkologie· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DCE-MRI assessment of the effect of vandetanib on tumor vasculature in patients with advanced colorectal cancer and liver metastases: a randomized phase I study.
Klaus Mross, Ulrike Fasol, Annette Frost, Robin Benkelmann, Jan Kuhlmann, Clemens Unger

J Angiogenes Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.
Peter Jantscheff, Norbert Esser, Ralph Graeser, Vittorio Ziroli, Jessica Kluth, Clemens Unger

Prostate· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer.
Ralph Graeser, Christian Bornmann, Norbert Esser, Vittorio Ziroli, Peter Jantscheff, Clemens Unger

Pancreas· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.
Bernd Hildenbrand, Dirk Lorenzen, Barbara Sauer, Christian Hertkorn, Marina A Freudenberg, Clemens Unger

Anticancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model.
Jens Soltau, Ute Zirrgiebel, Norbert Esser, Christoph Schächtele, Frank Totzke, Clemens Unger

Anticancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II study.
Simone Steinbild, Jann Arends, Michael Medinger, Brigitte Häring, Annette Frost, Clemens Unger

Onkologie· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis